Abbott Laboratories (LON:0Q15)

Market Cap	167.25B
Revenue (ttm)	31.47B
Net Income (ttm)	10.17B
Shares Out	n/a
EPS (ttm)	5.82
PE Ratio	16.45
Forward PE	23.38
Dividend	1.79 (1.42%)
Ex-Dividend Date	Jul 15, 2025

Volume	898
Average Volume	9,843
Open	126.30
Previous Close	127.68
Day's Range	124.87 - 127.72
52-Week Range	103.70 - 141.41
Beta	0.66
RSI	45.36
Earnings Date	Jul 16, 2025

About Aspen Technology

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism,...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1888
• Employees: 114,000
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0Q15

Financial Performance

In 2024, Abbott Laboratories's revenue was $41.95 billion, an increase of 4.59% compared to the previous year's $40.11 billion. Earnings were $13.35 billion, an increase of 134.19%.